FDA Inspection 1152144 — Sichuan Qingmu Pharmaceutical Co., Ltd
The FDA completed an inspection of Sichuan Qingmu Pharmaceutical Co., Ltd on September 7, 2021 in Meishan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 7, 2021
- Fiscal Year
- 2021
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Meishan (China)